Long term outcomes of hepatic resection following orthotopic liver transplant

2021 ◽  
Author(s):  
Skyle Murphy ◽  
Peter Hodgkinson ◽  
Thomas R. O'Rourke ◽  
Kellee Slater ◽  
Shinn Yeung ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Hepatic Resection ◽  
Orthotopic Liver Transplant ◽  
Long Term Outcomes

scholarly journals Long Term Outcomes of Hepatic Resection Following Orthotopic Liver Transplant

HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S101
Author(s):  
S. Murphy ◽  
P. Hodgkinson ◽  
T. O-Rourke ◽  
K. Slater ◽  
S. Yeung ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Hepatic Resection ◽  
Orthotopic Liver Transplant ◽  
Long Term Outcomes

Fixed-to-Last: Long-Term Outcomes of Orthotopic Liver Transplant Biliary Complications Managed Endoscopically

2008 ◽  
Vol 67 (5) ◽  
pp. AB158
Author(s):  
Anthony Schore ◽  
Denise M. Harnois ◽  
Justin H. Nguyen ◽  
Andrew Stockland ◽  
Michael B. Wallace ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Orthotopic Liver Transplant ◽  
Biliary Complications ◽  
Long Term Outcomes

scholarly journals Age-adjusted Charlson-comorbidity Index Predicts Short-term and Long-term Outcomes after Hepatic Resection of Hepatocellular Carcinoma

HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S33
Author(s):  
H. Shinkawa ◽  
S. Tanaka ◽  
S. Takemura ◽  
R. Amano ◽  
K. Kimura ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatic Resection ◽  
Charlson Comorbidity Index ◽  
Long Term Outcomes ◽  
Short Term ◽  
Comorbidity Index

Probability, management, and long-term outcomes of biliary complications after hepatic artery thrombosis in liver transplant recipients

Surgery ◽  
2017 ◽  
Vol 162 (5) ◽  
pp. 1101-1111 ◽  
Author(s):  
Masato Fujiki ◽  
Koji Hashimoto ◽  
Emmanouil Palaios ◽  
Cristiano Quintini ◽  
Federico N. Aucejo ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Hepatic Artery ◽  
Biliary Complications ◽  
Hepatic Artery Thrombosis ◽  
Transplant Recipients ◽  
Long Term Outcomes ◽  
Artery Thrombosis ◽  
Liver Transplant Recipients

scholarly journals Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus

2018 ◽  
Vol 2 (11) ◽  
pp. 1314-1319 ◽  
Author(s):  
Suruchi Gupta ◽  
Teresa Pollack ◽  
Candice Fulkerson ◽  
Kathleen Schmidt ◽  
Diana Johnson Oakes ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Liver Transplant ◽  
Controlled Trial ◽  
Organ Transplant ◽  
Long Term Outcomes ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Persistent Hyperglycemia

Abstract Objective To characterize the types of hyperglycemia that occur up to 1 year following liver transplant and to clarify the nomenclature for posttransplant hyperglycemia. Design We analyzed 1-year glycemic follow-up data in 164 patients who underwent liver transplant and who had been enrolled in a randomized controlled trial comparing moderate to intensive insulin therapy to determine if patients had preexisting known diabetes, transient hyperglycemia, persistent hyperglycemia, or new-onset diabetes after transplantation (NODAT). Results Of 119 patients with posttransplant hyperglycemia following hospital discharge, 49 had preexisting diabetes, 5 had insufficient data for analysis, 48 had transient hyperglycemia (16 resolved within 30 days and 32 resolved between 30 days and 1 year), 13 remained persistently hyperglycemic out to 1 year and most likely had preexisting diabetes that had not been diagnosed or insulin resistance/insulinopenia prior to transplant, and 4 had NODAT (i.e., patients with transient hyperglycemia after transplant that resolved but then later truly developed sustained hyperglycemia, meeting criteria for diabetes). Conclusions Distinct categories of patients with hyperglycemia following organ transplant include known preexisting diabetes, persistent hyperglycemia (most likely unknown preexisting diabetes or insulin resistance/insulinopenia), transient hyperglycemia, and NODAT. Those with preexisting diabetes for many years prior to transplant may well have very different long-term outcomes compared with those with true NODAT. Therefore, it would be prudent to classify patients more carefully. Long-term outcome studies are needed to determine if patients with true NODAT have the same poor prognosis as patients with preexisting diabetes (diagnosed and undiagnosed) undergoing transplant.

scholarly journals The Impact on the Long-term Outcomes of Hormonal Status After Hepatic Resection for Breast Cancer Liver Metastases

In Vivo ◽  
2018 ◽  
Vol 32 (5) ◽  
pp. 1247-1253 ◽  
Author(s):  
NICOLAE BACALBASA ◽  
IRINA BALESCU ◽  
VERONICA ILIE ◽  
RALUCA FLOREA ◽  
ANDREI SOROP ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Liver Metastases ◽  
Hepatic Resection ◽  
Hormonal Status ◽  
Long Term Outcomes ◽  
The Impact ◽  
Breast Cancer Liver Metastases

Long-Term Outcomes Among HIV-Infected Liver Transplant Recipients.

2014 ◽  
Vol 98 ◽  
pp. 774
Author(s):  
J. Locke ◽  
A. Massie ◽  
R. Reed ◽  
D. Segev
Keyword(s):  
Liver Transplant ◽  
Transplant Recipients ◽  
Long Term Outcomes ◽  
Infected Liver ◽  
Liver Transplant Recipients

Long-term outcomes of hepatic resection for colorectal liver metastases at a New Zealand tertiary level public hospital

2016 ◽  
Vol 86 (4) ◽  
pp. 285-288 ◽  
Author(s):  
Elizabeth W. Foo ◽  
Tom Moore ◽  
Dean Harris ◽  
Ma Yi ◽  
Saxon Connor
Keyword(s):  
New Zealand ◽  
Liver Metastases ◽  
Hepatic Resection ◽  
Colorectal Liver Metastases ◽  
Public Hospital ◽  
Tertiary Level ◽  
Long Term Outcomes

Orthotopic liver transplant and hepatic resection: Lessons learned from complimentary disciplines

2002 ◽  
Vol 59 (5) ◽  
pp. 468-473
Author(s):  
L.James Wudel ◽  
Steven C. Stain ◽  
C.Wright Pinson ◽  
William C. Chapman
Keyword(s):  
Liver Transplant ◽  
Hepatic Resection ◽  
Lessons Learned ◽  
Orthotopic Liver Transplant
Sign in / Sign up

Export Citation Format

Share Document